Regeneron’s antibody cocktail is a combination of casirivimab and imdevimab, two antibodies that fight against COVID-19. The FDA granted it emergency use authorization Nov. 21.
The West Virginia National Guard said the error does not pose a risk to the 42 individuals. It also said those 42 people “will be offered the vaccine as soon as possible with a priority status,” according to the Washington Post.
More articles on pharmacy:
6 recent drug, device recalls
340B discounts apply to contract pharmacies, HHS clarifies
Pfizer vs. Moderna COVID-19 vaccine: What’s the same & what’s different
6 recent drug, device recalls
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
